Indoleamine 2,3-Dioxygenase Expression in Transplanted NOD Islets Prolongs Graft Survival After Adoptive Transfer of Diabetogenic Splenocytes
Authors:
Open Access
- 1 February 2002
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 51 (2) , 356-365
Abstract
Indoleamine 2,3-dioxygenase (IDO) catalyzes the breakdown of the amino acid tryptophan into kyneurenine. It has been shown that IDO production by placental trophoblasts prevents the attack of maternal T-cells activated in response to the paternal HLA alleles expressed by the tissues of the fetus. In this article, we show that adenoviral gene transfer of IDO to pancreatic islets can sufficiently deplete culture media of tryptophan and consequently inhibit the proliferation of T-cells in vitro. Experiments in vivo have also demonstrated that transplantation of IDO-expressing islets from prediabetic NOD mouse donors into NODscid recipient mice is associated with a prolongation in islet graft survival after adoptive transfer of NOD diabetogenic T-cells. This protection is attributed to the depletion of tryptophan at the transplantation site beneath the kidney capsule. These results suggest that local modulation of tryptophan catabolism may be a means of facilitating islet transplantation as a therapy for type 1 diabetes.Keywords
This publication has 41 references indexed in Scilit:
- Protection of Human Islets from the Effects of Interleukin-1β by Adenoviral Gene Transfer of an IκB RepressorJournal of Biological Chemistry, 2000
- Prevention of Type 1 Diabetes: PerspectivesThe Journal of Clinical Endocrinology & Metabolism, 2000
- Infection of intact human islets by a lentiviral vectorGene Therapy, 1999
- Interferon‐γ‐Induced Activation of Indoleamine 2,3‐Dioxygenase in Cord Blood Monocyte‐Derived Macrophages Inhibits the Growth of Group B StreptococciThe Journal of Infectious Diseases, 1998
- THE role of indoleamine 2,3‐dioxygenase in the anti‐tumour activity of human interferon‐γ in vivoInternational Journal of Cancer, 1995
- Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donorsDiabetes, 1993
- Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) miceDiabetes, 1986
- Type I Diabetes MellitusNew England Journal of Medicine, 1986
- A severe combined immunodeficiency mutation in the mouseNature, 1983
- Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis. An observation in nonobese diabetic (NOD) miceDiabetes, 1982